JP2004534533A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004534533A5 JP2004534533A5 JP2003500199A JP2003500199A JP2004534533A5 JP 2004534533 A5 JP2004534533 A5 JP 2004534533A5 JP 2003500199 A JP2003500199 A JP 2003500199A JP 2003500199 A JP2003500199 A JP 2003500199A JP 2004534533 A5 JP2004534533 A5 JP 2004534533A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- peptide
- condition
- ntp peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29315601P | 2001-05-25 | 2001-05-25 | |
| PCT/CA2002/000759 WO2002097030A2 (en) | 2001-05-25 | 2002-05-24 | Peptides derived from neural thread proteins and their medical use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004534533A JP2004534533A (ja) | 2004-11-18 |
| JP2004534533A5 true JP2004534533A5 (https=) | 2005-12-22 |
| JP4584573B2 JP4584573B2 (ja) | 2010-11-24 |
Family
ID=23127882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003500199A Expired - Fee Related JP4584573B2 (ja) | 2001-05-25 | 2002-05-24 | 細胞の除去または破壊を必要とする腫瘍および他の状態の処置に有効なペプチド |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6924266B2 (https=) |
| EP (1) | EP1390403B1 (https=) |
| JP (1) | JP4584573B2 (https=) |
| KR (1) | KR100945383B1 (https=) |
| CN (1) | CN1582301A (https=) |
| AT (1) | ATE350396T1 (https=) |
| AU (1) | AU2002256587B2 (https=) |
| BR (1) | BR0209990A (https=) |
| CA (1) | CA2448348C (https=) |
| CY (1) | CY1111120T1 (https=) |
| DE (1) | DE60217326T2 (https=) |
| DK (1) | DK1390403T3 (https=) |
| ES (1) | ES2278916T3 (https=) |
| NO (1) | NO334189B1 (https=) |
| NZ (1) | NZ529911A (https=) |
| PT (1) | PT1390403E (https=) |
| WO (1) | WO2002097030A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002304314B2 (en) * | 2001-03-08 | 2007-09-06 | Nyomox Pharmaceutical Corporation | Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| IL159903A0 (en) * | 2001-07-19 | 2004-06-20 | Nymox Corp | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| EP1847550A3 (en) * | 2001-07-19 | 2008-01-09 | Nymox Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| CA2555306A1 (en) * | 2004-02-06 | 2005-08-18 | Nymox Corporation | Humanized antibody |
| WO2005089398A2 (en) * | 2004-03-18 | 2005-09-29 | St. Luke's Hospital | Method for the delivery of sustained release agents |
| EA200801942A1 (ru) * | 2006-03-10 | 2009-02-27 | Наймокс Корпорейшн | Способ предотвращения или уменьшения риска возникновения рака с использованием пептидов на основе белков нервных волокон |
| CN101215323B (zh) * | 2007-12-28 | 2011-11-30 | 首都医科大学宣武医院 | 人ad7c-ntp抗原决定簇多肽、抗体及其在诊断试剂盒上的应用 |
| US20160361380A1 (en) | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
| US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
| US10835538B2 (en) | 2018-03-28 | 2020-11-17 | Nymox Corporation | Method of treating benign prostatic hyperlasia with antibiotics |
| US20200061150A1 (en) | 2018-08-23 | 2020-02-27 | Nymox Corporation | Method of inducing selective prostate glandular pharmaco-ablation with sparing of nerves and preservation of sexual function |
| US20200360466A1 (en) | 2019-05-13 | 2020-11-19 | Nymox Corporation | Method of improving lower urinary tract symptoms |
| US11298400B2 (en) | 2019-05-13 | 2022-04-12 | Nymox Corporation | Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS |
| US11278588B2 (en) | 2019-05-13 | 2022-03-22 | Nymox Corporation | Method of treating lower urinary tract symptoms with fexapotide triflutate |
| US11231421B2 (en) | 2019-07-31 | 2022-01-25 | Nymox Corporation | Methods of treating multifocal cancer |
| US11331374B2 (en) | 2019-07-31 | 2022-05-17 | Nymox Corporation | Focal treatment of prostate cancer |
| CN111579799A (zh) * | 2020-06-23 | 2020-08-25 | 江苏省荣军医院 | 一种检测尿液中阿尔茨海默病相关神经丝蛋白的荧光免疫层析试纸的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990006993A1 (en) * | 1988-12-21 | 1990-06-28 | The General Hospital Corporation | Method of detecting neurological disease or dysfunction |
| US5948634A (en) * | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
| CA2282729A1 (en) * | 1997-02-26 | 1998-09-03 | The General Hospital Corporation | Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| WO1999019347A1 (en) | 1997-10-10 | 1999-04-22 | Astrazeneca Ab | Synthetic genes with immunomodulatory effects |
| AU765110B2 (en) * | 1998-06-26 | 2003-09-11 | Georgetown University Medical Center | Compositions and methods for inducing cell death |
| AU2185199A (en) * | 1998-09-30 | 2000-04-17 | Yoko Aida | Apoptosis inducers |
| AU2373800A (en) | 1998-12-11 | 2000-06-26 | Incyte Pharmaceuticals, Inc. | Neuron-associated proteins |
| DE60003632T2 (de) * | 1999-01-11 | 2004-04-15 | Leadd B.V. | Verwendung von apoptose-induzierende mittel zur herstellung eines mittels zur behandlung von (auto)immunkrankheiten |
| WO2000063230A2 (en) * | 1999-03-26 | 2000-10-26 | Human Genome Sciences, Inc. | 49 human secreted proteins |
| AU3769700A (en) | 1999-03-26 | 2000-10-16 | Human Genome Sciences, Inc. | 45 human secreted proteins |
| US7259232B1 (en) | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
| AU2002304314B2 (en) | 2001-03-08 | 2007-09-06 | Nyomox Pharmaceutical Corporation | Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| DK1392347T3 (da) | 2001-05-16 | 2005-12-12 | Nymox Corp | Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteiner |
-
2002
- 2002-05-24 DK DK02726037T patent/DK1390403T3/da active
- 2002-05-24 ES ES02726037T patent/ES2278916T3/es not_active Expired - Lifetime
- 2002-05-24 WO PCT/CA2002/000759 patent/WO2002097030A2/en not_active Ceased
- 2002-05-24 KR KR1020037015376A patent/KR100945383B1/ko not_active Expired - Fee Related
- 2002-05-24 CN CNA028149777A patent/CN1582301A/zh active Pending
- 2002-05-24 DE DE60217326T patent/DE60217326T2/de not_active Expired - Lifetime
- 2002-05-24 AT AT02726037T patent/ATE350396T1/de active
- 2002-05-24 PT PT02726037T patent/PT1390403E/pt unknown
- 2002-05-24 EP EP02726037A patent/EP1390403B1/en not_active Expired - Lifetime
- 2002-05-24 BR BR0209990-0A patent/BR0209990A/pt not_active IP Right Cessation
- 2002-05-24 NZ NZ529911A patent/NZ529911A/en not_active IP Right Cessation
- 2002-05-24 US US10/153,334 patent/US6924266B2/en not_active Expired - Fee Related
- 2002-05-24 AU AU2002256587A patent/AU2002256587B2/en not_active Ceased
- 2002-05-24 CA CA2448348A patent/CA2448348C/en not_active Expired - Fee Related
- 2002-05-24 JP JP2003500199A patent/JP4584573B2/ja not_active Expired - Fee Related
-
2003
- 2003-11-25 NO NO20035231A patent/NO334189B1/no not_active IP Right Cessation
-
2007
- 2007-03-12 CY CY20071100339T patent/CY1111120T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005507647A5 (https=) | ||
| JP2004534533A5 (https=) | ||
| JP2005506061A5 (https=) | ||
| JP2005521383A5 (https=) | ||
| JP2004529908A5 (https=) | ||
| ES2342416T3 (es) | Procedimiento de purificacion o produccion de una proteina mage. | |
| CN102596217B (zh) | 经修饰的血管活性肠肽 | |
| JP2003531632A (ja) | グルカゴンアンタゴニスト | |
| CA2438143A1 (en) | Modified proteins, designer toxins, and methods of making thereof | |
| JPH06502771A (ja) | 筋細胞内での発現のためのウイルス性組換え型ベクター | |
| JP2005530484A5 (https=) | ||
| WO1999048923A1 (en) | Multivalent ligands which modulate angiogenesis | |
| JP2003505075A5 (https=) | ||
| JP2021515572A5 (https=) | ||
| CN113194978A (zh) | 具有间充质干细胞的动员活性的肽 | |
| JP2003530870A (ja) | Ａｐｏ−ＡＩ／ＡＩＩペプチド誘導体 | |
| CN111690071A (zh) | 一种具有靶向穿膜性的抗肿瘤多肽 | |
| CN119019494A (zh) | 一种治疗心梗的脐带间充质干细胞及其制备方法和应用 | |
| JPH08507205A (ja) | 軟骨礎質の形成を促進する方法 | |
| CN1339973A (zh) | 糖尿病性局部缺血疾病的基因治疗 | |
| JP7457413B2 (ja) | 代謝障害に対する新規なｆｇｆ１９タンパク質類似物質及びその使用 | |
| US20080145412A1 (en) | Method of promoting angiogenesis | |
| KR102460983B1 (ko) | 새로운 재생 치료제로서의 camkk1 | |
| CN100535005C (zh) | 长链人胰岛素样生长因子(lr3igf-1)及其制备和应用方法 | |
| CN115605502A (zh) | 用于预防或治疗纤维化疾病的重组融合蛋白 |